BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8899340)

  • 1. Ukrain therapy of recurrent breast cancer with lung metastases (case report).
    Kadan P; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):243-5. PubMed ID: 8899340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ukrain treatment in a patient with breast carcinoma. Case report.
    Zemskov SV; Prokopchuk OL; Susak YM
    Drugs Exp Clin Res; 2000; 26(5-6):253-4. PubMed ID: 11345033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ukrain with chemotherapy in malignant melanoma (case report).
    Stabuc B; Benedicic D
    Drugs Exp Clin Res; 1996; 22(3-5):231-3. PubMed ID: 8899337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report).
    Schramm E; Nowicky JW; Godysh Y
    Drugs Exp Clin Res; 1996; 22(3-5):247-54. PubMed ID: 8899341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Ukrain on patients with surgically treated breast cancer (introductory remarks).
    Uglyanica KN; Fomin KA; Nefyodov LI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):123-5. PubMed ID: 8899314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report).
    Steinacker J; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):279-81. PubMed ID: 8899348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ukrain treatment in carcinoma of the oesophagus (case report).
    Vyas JJ; Jain VK
    Drugs Exp Clin Res; 1996; 22(3-5):267-9. PubMed ID: 8899345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Ukrain on breast cancer.
    Brzosko WJ; Uglyanica KN; Fomin KA; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):127-33. PubMed ID: 8899315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Ukrain on patients with surgically treated breast cancer. Part I. Clinical and laboratory parameters.
    Uglyanica KN; Fomin KA; Nefyodov LI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):135-8. PubMed ID: 8899316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Ukrain on patients with surgically treated breast cancer. Part IV. Electromicroscopic and cytochemical evaluation.
    Uglyanica KN; Maciuk JR; Fomin KA; Nefyodov LI; Kravchuk RI; Vinogradova LM; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):147-53. PubMed ID: 8899319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acids and their derivatives in tumour tissue from patients with breast cancer treated with Ukrain. Part VI.
    Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):159-61. PubMed ID: 8899321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy of Ukrain in the treatment of breast cancer: clinical and laboratory studies.
    Uglianitsa KN; Nefyodov LI; Brzosko W
    Drugs Exp Clin Res; 1998; 24(5-6):231-9. PubMed ID: 10190080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ukrain in the treatment of urethral recurrent carcinoma (case report).
    Kadan P; Korsh OB; Hiesmayr W
    Drugs Exp Clin Res; 1996; 22(3-5):271-3. PubMed ID: 8899346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.
    Uglyanitsa KN; Nefyodov LI; Brzosko V
    Drugs Exp Clin Res; 2000; 26(5-6):223-30. PubMed ID: 11345029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer.
    Susak YM; Zemskov VS; Yaremchuk OY; Kravchenco OB; Yatsyk IM; Korsh OB
    Drugs Exp Clin Res; 1996; 22(3-5):115-22. PubMed ID: 8899313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids and their derivatives in blood plasma of patients with breast cancer treated with Ukrain. Part V.
    Nefyodov LI; Uglyanica KN; Smirnov VY; Doroshenko YM; Fomin KA; Nowicky JW; Brzosko WJ
    Drugs Exp Clin Res; 1996; 22(3-5):155-7. PubMed ID: 8899320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
    Fomin KA; Uglyanica KN; Nefyodov LI; Djurd TI; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):143-5. PubMed ID: 8899318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Ukrain on patients with surgically treated breast cancer. Part II. Hormonal profile.
    Uglyanica KN; Fomin KA; Nefyodov LI; Vilkiewich TW; Nowicky JW; Brzosko WJ; Jankowski A
    Drugs Exp Clin Res; 1996; 22(3-5):139-41. PubMed ID: 8899317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ukrain therapy of stage T1N0M0 bladder cancer patients.
    Uglianitsa KN; Nechiporenko NA; Nefyodov LI; Brzosko WJ
    Drugs Exp Clin Res; 1998; 24(5-6):227-30. PubMed ID: 10190079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain.
    Uglyanitsa KN; Nefyodov LI; Karayedova LM; Nowicky JW; Brzosko W
    Drugs Exp Clin Res; 2000; 26(5-6):239-47. PubMed ID: 11345031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.